Skip to main content

Polatuzumab Vedotin-piiq

Placeholder slot
 (POH-lah-TOO-zoo-mab veh-DOH-tin)

This page contains brief information about polatuzumab vedotin-piiq and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Polatuzumab vedotin-piiq is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that polatuzumab vedotin-piiq provides a clinical benefit in these patients.

Polatuzumab vedotin-piiq is also being studied in the treatment of other types of cancer.

More About Polatuzumab Vedotin-piiq

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Biological Therapies for Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Polatuzumab Vedotin-piiq - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: